The commercial launch of the integrated products provides people with type 1 diabetes a new level of flexibility and personalization in their diabetes management. Pairing twiist™ with Senseonics’ ...
Welldoc®, a leader in AI-powered cardiometabolic health solutions, today announced the submission of a 510(k) premarket ...
Abbott, the creator of continuous glucose monitors, launched the new Assist feature at CES 2026. Part of the Libre app, it ...
Adults with type 1 or type 2 diabetes who used a continuous glucose monitor experienced fewer emergency department and ...
Please provide your email address to receive an email when new articles are posted on . Studies have found discordance between HbA1c and glucose management indicator. HbA1c remains the standard for ...
Concerning’ disparities in access to continuous glucose monitors despite black and south Asian people being more likely to live with condition ...
In early January 2026, Abbott Laboratories unveiled Libre Assist, an AI-powered feature within its Libre app that helps U.S.
Adults with uncontrolled type 1 diabetes saw a benefit when using intermittently scanned continuous glucose monitoring (CGM), the randomized FLASH-UK Trial showed. Compared with traditional ...
SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, commends the expansion of CGM Medicare coverage to ...
Dallas Waldon doesn't have diabetes, but she says she benefits from continuous glucose monitoring (CGM). "I'm a huge fan of CGMs and used them before, during and after my pregnancy, [up to] 6 months ...
In patients with type 1 diabetes, use of continuous glucose monitoring (CGM) devices -- alone or with insulin pumps -- was associated with lower odds of developing diabetic retinopathy and ...
Time-in-range (TIR) readings from a continuous glucose monitor (CGM) complemented A1c readings and provided a more complete picture of glucose control in patients with type 2 diabetes taking basal ...